Skip to content
2000
Volume 27, Issue 41
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Breast cancer is the most common cancer in women worldwide. Due to the heterogeneous nature of breast cancer, the optimal treatment and expected response for each patient may not necessarily be universal. Molecular imaging techniques could play an important role in the early detection and targeted therapy evaluation of breast cancer. This review focuses on the development of peptides labeled with SPECT and PET radionuclides for breast cancer imaging. We summarized the current status of radiolabeled peptides for different receptors in breast cancer. The characteristics of radionuclides and major techniques for peptide labeling are also briefly discussed.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867327666200128110827
2020-12-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867327666200128110827
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test